Professional Documents
Culture Documents
Allergic Rhinitis
Background
Rhinitis is defined as inflammation of
the nasal membranes and is
characterized
characterize d by a symptom complex
that consists of any combination of the
following: sneezing, nasal congestion,
nasal itching, and rhinorrhea. Allergic
rhinitis is the most common cause of
rhinitis.
Background
Total cost $5.3 billion per year. (in
America)
Morbidity 10%-40% ( in China)
Classification
Pathophysiology
Allergic reaction
reaction is an exaggerated
exaggerated or
inappropriate
causes damage immune
to the reaction
host and
Type I immediate hypersensitivity
reaction
mediated by IgE antibodies,
which trigger the mast cells and
basophils to release pharmacologically
active agents.
CLINICAL
History: Obtaining a detailed history is
important in the evaluation of allergic rhinitis.
Allergy history
environmental exposures
occupational exposures
effects on quality of life
Family history
Past medical history
CLINICAL
Signs and Symptoms of Allergic Rhinitis
Sneezing
Itching (nose, eyes, ears, palate)
Rhinorrhea(watery secretions)
Congestion
Hyposmia (嗅觉下降)
CLINICAL
"Allergic shiners"
"Nasal crease"
(allergic salute).
Nasal
examination :swol
len (boggy), pale,
blue-gray mucosa
Lab Studies
Lab Studies
Finding allergen
a. Skin testing: prick test
(点刺试验)
intracutaneous test
(皮内试验)
b. Nasal allergen challenge test
c. Serum special IgE determination
Diagnosis
history
Clinical manifestation
Allergy diagnosis
Differential Diagnosis
Complication
Allergic sinusitis
过敏性鼻窦炎
过敏性鼻窦炎
Asthma
哮喘
Secretory otitis media
泌性 耳炎
Treatment
Medical Care
(1) Avoidance
Environmental controls and
allergen avoidance
(2) Pharmacothera
Pharmacotherapy
py
(3) Immunotherapy
Treatment
(2) Pharmacotherapy
a. Steroid: topical—nasal steroid sprays
general
b.Antihistamines: H1-receptor antagonist
First-generation:: toldrin (drowsiness )
First-generation
Second-generation:cl
generation:clarity
arity (don’t cross the
blood- brain barrier)
c.Mast cell stabilizing drug:disodium cromoglycate
d. Decongesta
Decongestantsnts
Treatment
(3) Immunothera
Immunotherapy
py
Exact mechanism unknown
Decrease allergen-specific IgE levels
Increase allergen-specific IgG levels
IgG molecules ( blocking antibodies
that are important in impeding the
allergic reaction. )
Treatment
(3) Immunotherapy
method: increasing doses of injected allergen
until the maximum tolerated dose is
reached
maintenance dose(maximum tolerated dose )
Treatment
Surgical Care: Surgical care is not
indicated for allergic rhinitis but may be
indicated for comorbid or complicating
conditions.
Patient Education
Question
What are the major symptoms of allergic
rhinitis?